David Cole to Treatment Outcome
This is a "connection" page, showing publications David Cole has written about Treatment Outcome.
Connection Strength
0.145
-
The South Carolina Surgical Quality Collaborative: A New Effort to Improve Surgical Outcomes in South Carolina. Am Surg. 2018 Jun 01; 84(6):916-919.
Score: 0.067
-
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host. J Am Coll Surg. 2012 Apr; 214(4):700-7; discussion 707-8.
Score: 0.043
-
Phase I trial of recombinant human macrophage colony-stimulating factor administered by continuous intravenous infusion in patients with metastatic cancer. J Natl Cancer Inst. 1994 Jan 05; 86(1):39-45.
Score: 0.012
-
Complications of hepatic resection for colorectal carcinoma metastasis. Am Surg. 1992 Feb; 58(2):88-91.
Score: 0.011
-
The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. Br J Cancer. 2000 Jul; 83(1):16-21.
Score: 0.005
-
Trends in indications and outcomes in the Whipple procedure over a 40-year period. Am Surg. 1999 Sep; 65(9):889-93.
Score: 0.005
-
Combined surgery and radiotherapy for conservative management of soft tissue sarcomas. Recent Results Cancer Res. 1995; 138:47-55.
Score: 0.003